Targeted nutlin-3a loaded nanoparticles inhibiting p53–MDM2 interaction: novel strategy for breast cancer therapy

Nanomedicine ◽  
2011 ◽  
Vol 6 (3) ◽  
pp. 489-507 ◽  
Author(s):  
Manasi Das ◽  
Fahima Dilnawaz ◽  
Sanjeeb K Sahoo
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Breast Cancer Therapy ◽  
Novel Strategy

scholarly journals A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy

2017 ◽  
Vol 8 (3) ◽  
pp. 135-142 ◽  
Author(s):  
Irida Kastrati ◽  
Marton I. Siklos ◽  
Svitlana D. Brovkovych ◽  
Gregory R. J. Thatcher ◽  
Jonna Frasor
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Therapy ◽  
Nuclear Factor Κb ◽  
Nuclear Factor ◽  
Breast Cancer Therapy ◽  
Hybrid Drugs ◽  
Novel Strategy

Novel strategy for breast cancer therapy

Breast Cancer ◽  
2006 ◽  
Vol 13 (1) ◽  
pp. 1-1
Author(s):  
Minoru Fujimori
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Breast Cancer Therapy ◽  
Novel Strategy

(TA)MUC1 as a potential new target for breast cancer therapy

2020 ◽  
Author(s):  
AS Heimes ◽  
P Fries ◽  
N Stergiou ◽  
R Attariya ◽  
A Hasenburg ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Breast Cancer Therapy

Off-label drug use in breast cancer therapy

Oncoreview ◽  
2017 ◽  
Vol 7 (2) ◽  
pp. 83-87
Author(s):  
Tomasz Jankowski ◽  
Monika Urbaniak
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Drug Use ◽  
Breast Cancer Therapy ◽  
Off Label
Sign in / Sign up

Export Citation Format

Share Document